Apteki 36.6 Financial Statements (APTK)

Аптеки 36 и 6smart-lab.ru   2020 2021 2022 2023 2024
Report date 30.04.2021 08.08.2023 17.07.2023 02.05.2024 29.04.2025
Currency RUB RUB RUB RUB RUB
Financial report URL
Annual report URL
Number of stores, pcs. 2 554
New stores opened, pcs. 403
Revenue, bln rub ? 39.3 44.1 59.1 67.4 87.2
Operating Income, bln rub 4.27 6.76
EBITDA, bln rub ? 4.70 5.89 8.55
Net profit, bln rub ? 6.40 -0.950 0.223 0.921 0.866
Net profit not adj., bln rub ? 0.120 0.267
OCF, bln rub ? 3.23 6.60 7.05 6.49
CAPEX, bln rub ? 1.70 0.980 0.980 1.28 1.51
FCF, bln rub ? -1.71 1.64 1.93 0.450
Ordinary share dividend yield, % 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend payout ratio, % 0% 0% 0% 0% 0%
OPEX, bln rub 18.1 22.0
Cost of production, bln rub 25.7 29.0 38.9 45.1 58.7
Amortization, bln rub 5.8 5.8 6.0 6.6
Employment expenses, bln rub 6.27 6.78 7.92 8.91 11.6
Interest expenses, bln rub 4.05 4.92 4.27 2.44 4.27
Assets, bln rub 54.4 37.8 43.6 53.2 60.8
Net Assets, bln rub ? -5.70 -6.65 -6.41 -6.83 -7.56
Debt, bln rub 40.2 21.6 18.9 20.7 23.1
Cash, bln rub 1.000 1.73 0.810 2.09 1.96
Net debt, bln rub 39.2 19.9 18.1 18.6 21.2
Ordinary share price, rub 14.0 14.0 11.6 14.2 11.5
Number of ordinary shares, mln 2 331 2 331 2 331 7 630 7 630
Market cap, bln rub 32.5 32.5 27.0 108.5 87.7
EV, bln rub ? 71.7 52.4 45.1 127.1 108.9
Book value, bln rub -18.2 -19.5 -19.9 -24.0 -27.2
EPS, rub ? 2.75 -0.41 0.10 0.12 0.11
FCF/share, rub 0.00 -0.73 0.70 0.25 0.06
BV/share, rub -7.81 -8.37 -8.54 -3.15 -3.56
EBITDA margin, % ? 12.0% 0.0% 0.0% 8.7% 9.8%
Net margin, % ? 16.3% -2.2% 0.4% 1.4% 1.0%
FCF yield, % ? 0.0% -5.3% 6.1% 1.8% 0.5%
ROE, % ? -112.3% 14.3% -3.5% -13.5% -11.5%
ROA, % ? 11.8% -2.5% 0.5% 1.7% 1.4%
P/E ? 5.08 -34.2 120.9 117.8 101.3
P/FCF -19.0 16.4 56.2 195.0
P/S ? 0.83 0.74 0.46 1.61 1.01
P/BV ? -1.79 -1.67 -1.35 -4.52 -3.23
EV/EBITDA ? 15.2 21.6 12.7
Debt/EBITDA 8.33 3.16 2.47
Employees, people 5 904
Labour productivity, mln rub/person/year 6.66
Expenses per employee, thousand rub 1 062
R&D/CAPEX, % 0.00% 0.00% 0.00% 0.00% 0.00%
CAPEX/Revenue, % 4% 2% 2% 2% 2%
Apteki 36.6 shareholders